Synchronous L1 Retrotransposition Drives Chromosomal Rearrangements in Cancer

LINE-1 (L1) retrotransposons comprise approximately 17% of the human genome and propagate through a copy-and-paste mechanism. Although most of the roughly 500,000 L1 copies are inactive, a subset remains capable of mobilization and can induce insertional mutagenesis. Somatic L1 insertions occur in about one-third of human cancers and have been shown to generate large genomic alterations, including megabase-scale deletions. Previous studies suggested that L1 activity may also produce structural rearrangements such as translocations; however, these events have been difficult to resolve using short-read sequencing. To overcome this limitation, Zumalave and colleagues applied long-read genome sequencing to tumors with exceptionally high L1 activity. They identified more than 6,000 somatic retrotransposition events, many of which were previously undetectable, including over 150 retrotransposon-mediated genomic rearrangements. Tracing insertions back to donor loci revealed that a small subset of evolutionarily young L1 elements accounted for a disproportionate share of activity. The analysis uncovered widespread rearrangements in which distant chromosomal breakpoints were bridged by L1 insertions. Many events involved interchromosomal exchanges, with one-third forming reciprocal translocations, while others generated inversions and complex multi-chromosomal rearrangements. Notably, many of the rearrangements arose from recombination between two independent but synchronous somatic L1 insertions. Integrating genetic and epigenetic profiling showed that biallelic TP53 alterations were associated with elevated retrotransposition in head and neck and colorectal cancers, consistent with a role for TP53 loss in permitting transposable element activation. Retrotransposon-mediated rearrangements correlated with overall L1 insertion load, and L1 promoter hypomethylation correlated with insertion frequency, highlighting epigenetic derepression as a key determinant of activity. The authors also found evidence that activation of genes involved in Fanconi anemia may contribute to L1-mediated rearrangements. Timing analyses indicated that most retrotransposition events occur early in tumor evolution, positioning L1 activation as an early driver of genomic instability. Together, these findings highlight L1 retrotransposition as a major and previously underrecognized mechanism of large-scale genome remodeling in cancer.Zumalave S, Santamarina M, Espasandín NP, Zamora J, Garcia-Souto D, Temes J, et al. Concurrent L1 retrotransposition events promote reciprocal translocations in human tumorigenesis. Science 2026 Feb 26 Epub ahead of print.Note: Research Watch is written by Cancer Discovery editorial staff. Readers are encouraged to consult the original articles for full details. For more Research Watch, visit Cancer Discovery online at https://aacrjournals.org/cdnews.